Literature DB >> 16858701

Practical, highly active, and enantioselective ferrocenyl-imidazoline palladacycle catalysts (FIPs) for the aza-Claisen rearrangement of N-para-methoxyphenyl trifluoroacetimidates.

Matthias E Weiss1, Daniel F Fischer, Zhuo-Qun Xin, Sascha Jautze, W Bernd Schweizer, René Peters.   

Abstract

Entities:  

Year:  2006        PMID: 16858701     DOI: 10.1002/anie.200601731

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


× No keyword cloud information.
  5 in total

1.  Palladacyclic imidazoline-naphthalene complexes: synthesis and catalytic performance in Pd(II)-catalyzed enantioselective reactions of allylic trichloroacetimidates.

Authors:  Jeffrey S Cannon; James H Frederich; Larry E Overman
Journal:  J Org Chem       Date:  2012-01-30       Impact factor: 4.354

2.  Intermolecular hydroamination of allenes with N-unsubstituted carbamates catalyzed by a gold(I) N-heterocyclic carbene complex.

Authors:  Robert E Kinder; Zhibin Zhang; Ross A Widenhoefer
Journal:  Org Lett       Date:  2008-06-21       Impact factor: 6.005

3.  Direct Enantioselective Addition of Alkynes to Imines by a Highly Efficient Palladacycle Catalyst.

Authors:  Camilla Pfeffer; Patrick Probst; Nick Wannenmacher; Wolfgang Frey; René Peters
Journal:  Angew Chem Int Ed Engl       Date:  2022-07-19       Impact factor: 16.823

4.  Enantioselective synthesis and application to the allylic imidate rearrangement of amine-coordinated palladacycle catalysts of cobalt sandwich complexes.

Authors:  Doyle J Cassar; Gennadiy Ilyashenko; Muhammad Ismail; James Woods; David L Hughes; Christopher J Richards
Journal:  Chemistry       Date:  2013-11-21       Impact factor: 5.236

5.  Stereospecific Asymmetric Synthesis of Tertiary Allylic Alcohol Derivatives by Catalytic [2,3]-Meisenheimer Rearrangements.

Authors:  Xin Yu; Nick Wannenmacher; René Peters
Journal:  Angew Chem Int Ed Engl       Date:  2020-04-30       Impact factor: 15.336

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.